X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.reuters.com/business/healthcare-pharmaceuticals/lonza-signs-manufacturing-agreement-with-oasmia-ovarian-cancer-drug-2022-03-21/
http://www.pharmafile.com/news/571751/oasmia-acquires-rights-cancer-drug-candidate-cantrixil-44m-deal
https://en.prnasia.com/releases/apac/kazia-licenses-cantrixil-a-clinical-stage-first-in-class-ovarian-cancer-drug-candidate-to-oasmia-pharmacetical-ab-310003.shtml
https://www.oasmia.com/en/oasmia-pharmaceutical-ab-signs-phase-1b-trial-agreement-with-sakk-the-swiss-group-for-clinical-cancer-research-for-evaluation-of-docetaxel-micellar/
https://www.oasmia.com/en/oasmia-pharmaceutical-announces-poster-presentation-at-american-society-of-clinical-oncology-2020-annual-meeting/
https://www.oasmia.com/en/oasmia-announces-outcome-of-strategic-review-to-deliver-long-term-profitable-growth-as-a-specialty-pharma-company/
https://www.oasmia.com/en/oasmia-receives-upfront-payment-of-20-musd-from-elevar/
Market Place
Share 
